Veterinary Medicine Information website

HIPRAVIAR-CLON/H120

Authorised
  • Infectious bronchitis virus, type Massachusetts, strain H120, Live
  • Newcastle disease virus, strain CLON CL/79, Live
Download as PDF

Product identification

Medicine name:
HIPRAVIAR-CLON/H120
Active substance:
  • Infectious bronchitis virus, type Massachusetts, strain H120, Live
  • Newcastle disease virus, strain CLON CL/79, Live
Target species:
  • Chicken (hen)
Route of administration:
  • In drinking water use
  • Oculonasal use
  • Nebulisation use

Product details

Active substance and strength:
  • Infectious bronchitis virus, type Massachusetts, strain H120, Live
    3.00
    log 10 50% embryo infective dose
    /
    0.03
    millilitre(s)
  • Newcastle disease virus, strain CLON CL/79, Live
    6.50
    log 10 50% embryo infective dose
    /
    0.03
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken (hen)
      • Meat and offal
        0
        day
  • Oculonasal use
    • Chicken (hen)
      • Meat and offal
        0
        day
  • Nebulisation use
    • Chicken (hen)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 160238
Date of authorisation status change: